# AgBiome

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/agbiome

- Industry: Chemicals
- Headquarters: US
- Website: www.agbiome.com
- Total disclosed funding: $234M
- Latest round: Series D (Nov 15, 2019)
- Investors on record: 16

## About

Based in North Carolina, US, and founded in 2012 by Eric Ward, Jeff Dangl, John Ryals, Paul Schulze-Lefert, and Scott Uknes (CEO), AgBiome, LLC is a biotechnology company that delivers research and discovery to the agriculture industry by developing biological products. The firm raised a total funding of USD 233 million as of September 2021 from investors including Polaris Partners, Syngenta Ventures, and Pontifax Venture Capital, among others.

AgBiome, LLC develops and provides innovative biological and trait products for crop protection. Its product, Howler fungicide, harnesses the power of the plant microbiome and works on more than 300 crop-disease combinations. The firm's products help farmers combat unsolved problems in agriculture, including insects, nematodes, and diseases. Its product archive includes Azomar insecticide, Mazolin fungicide, Lektivar 40SC (fungicide), Marazo (fungicide), Perissim (fungicide), Miresa (fungicide) and Xiphosin fungicide. The firm also provides Genesis, a platform that captures and screens microbial collections for agriculturally relevant applications.

The firm plans to use its series D funding in September 2021 to expand its product portfolio, scale its scientific and commercial teams, and build its global presence and partnerships. It expects to launch its second product, Theia (fungicide), in early 2022 and launch 11 other products by 2025.

## Funding rounds

- Series D, Nov 15, 2019, $117M — ARCH Venture Partners, Polaris Partners, University of Texas Investment Management Company, Pontifax Venture Capital, Fidelity Investments, Bayer AG, Mosaic Company Pension Fund, Blue Horizon, Novalis LifeSciences
- Series C, Jul 17, 2018, $65M — ARCH Venture Partners, Innotech Advisers, Polaris Partners, University of Texas Investment Management Company, Pontifax Venture Capital, Fidelity Investments, Monsanto Growth Ventures
- Series B, Aug 20, 2015, $35M — ARCH Venture Partners, Innotech Advisers, Polaris Partners, University of Texas Investment Management Company, 180 Degree Capital, Pontifax Venture Capital, Bill and Melinda Gates Foundation, Monsanto Growth Ventures, Syngenta Ventures
- Series A, Nov 13, 2014, $3M — Syngenta, Novozymes A/S, Monsanto Growth Ventures
- Series A, Apr 11, 2013, $15M — ARCH Venture Partners, Innotech Advisers, Polaris Partners, 180 Degree Capital
- Seed, Dec 19, 2012 — Polaris Partners

## Investors

- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Seed, Series A, Series B, Series C, Series D
- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A, Series B, Series C, Series D
- Innotech Advisers — Series A, Series B, Series C
- 180 Degree Capital (https://capitalatlas.ai/funds/180-degree-capital) — Series A, Series B
- Syngenta — Series A
- Novozymes A/S — Series A
- Monsanto Growth Ventures (https://capitalatlas.ai/funds/monsanto-growth-ventures) — Series A, Series B, Series C
- University of Texas Investment Management Company — Series B, Series C, Series D
- Pontifax Venture Capital (https://capitalatlas.ai/funds/pontifax-venture-capital) — Series B, Series C, Series D
- Bill and Melinda Gates Foundation — Series B
- Syngenta Ventures (https://capitalatlas.ai/funds/syngenta-ventures) — Series B
- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series C, Series D
- Bayer AG — Series D
- Mosaic Company Pension Fund — Series D
- Blue Horizon (https://capitalatlas.ai/funds/blue-horizon) — Series D
- Novalis LifeSciences (https://capitalatlas.ai/funds/novalis-lifesciences) — Series D